Liberate Bio Announces Presentation to Update on RAPTOR LNP Platform and CAR-M Therapeutic Programs

Liberate Bio Announces Expansion of its Leadership Team

Taking an ‘upside-down’ approach to mRNA delivery

Deliver, but not to the liver: Liberate Bio developing targeted nucleic acid delivery technologies

Liberate Bio: Pushing into the Future of Therapeutic Vectors

Liberate Bio is Bringing Precision Delivery to Genetic Medicines